Landmark Study In The Lancet Oncology Shows Capecitabine (Xeloda(R))...

Full story: MediLexicon

An analysis conducted by the Finnish Breast Cancer Group and published in The Lancet Oncology shows women at intermediate to high-risk of early breast cancer recurrence who received capecitabine as part of their chemotherapy regimen had a 34% reduction in the risk of the disease returning or death, compared with those taking the chemotherapy ...

Leave a Comment

Comments

Type in your comments to post to the forum

Name
(appears on your post)

Comments

Type the numbers you see in the image on the right:

Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Other Recent Medication Discussions

Topic	Updated	Last By	Comments
KASPER is tool used to spot prescription drug a...	17 min	skykrystal	2
Claims administrator: Interim payments in $4.85... (Aug '08)	1 hr	Mr No Name	4614
Man arrested in sex for pills case (Sep '08)	2 hr	Herbert Spencer	361
Methadone clinic could cause problems	3 hr	PainFree	1798
Post a Comment	8 hr	Adam	2
Hundreds of New Mexicans OK'd as medical pot users	9 hr	joe el scalawag	35
FDA Says antiepileptic drugs patients have twic... (Oct '08)	9 hr	Riley	2